EICHOR
● Terminated
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
Condition: Factor VII Deficiency · Glanzmann Thrombasthenia · Hemophilia A With Inhibitor · Sponsor: Catalyst Biosciences
About this study
The purpose of the trial is to evaluate the PK, bioavailability, PD, efficacy and safety of MarzAA for on demand treatment and control of bleeding episodes in adult subjects with inherited bleeding disorders.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (20)
| UC Davis Medical Center | Sacramento, California, United States | — |
| University of California -San Francisco | San Francisco, California, United States | — |
| University of Colorado Hemophilia and Thrombosis Center | Aurora, Colorado, United States | — |
| Rush University | Chicago, Illinois, United States | — |
| Children's Hospital of Michigan | Detroit, Michigan, United States | — |
| Michigan State University Center for Bleeding Disorders & Clotting Disorders | East Lansing, Michigan, United States | — |
| East Carolina University | Greenville, North Carolina, United States | — |
| Mazumdar Shaw Medical Centre | Bengaluru, India | — |
| St. John's Medical College Hospital | Bengaluru, India | — |
| Amrita Institute of Medical Sciences and Research Centre | Kochi, India | — |
| K. J. Somaiya Hospital and Research Centre | Mumbai, India | — |
| Sahyadri Super Speciality Hospital | Pune, India | — |
+ 8 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04548791